SANTA ANA, CA - March 16, 2026 - PRESSADVANTAGE - Moment of Clarity has published a new educational resource detailing ...

Northwell Health is conducting a clinical trial to address treatment-resistant depression using similar technology used to treat neurological diseases like Parkinson’s in an effort to seek options for ...

Following a successful End-of-Phase 2 (EOP2) meeting with the U.S. Food and Drug Administration (FDA) announced in March 2026, the Phase 3 program for BPL-003 in TRD remains on track for initiation in ...

An AI-driven tool that tailors antidepressant treatment to individual patients was shown to improve outcomes for people with depression, compared to standard treatment, in a major international trial.

Learn more about a clinical trial examining a potential new treatment for depression in adult patients. Managing symptoms of depression can feel overwhelming, but you are not alone. If you experience ...

Understanding what depression is – and what it is not – is often the first step toward relief.

Patients with major depressive disorder, including those who have not responded to first-line antidepressants, may benefit from short-term nitrous oxide treatment, a major meta-analysis led by the ...

Prof. Dr. Guido van Wingen discusses the potential of, and barriers to, the use of AI in transforming the treatment of depression ...

AUSTIN (KXAN) — A faster treatment for postpartum depression is entering clinical trials at the University of Texas at Austin. It doesn’t require medication, anesthesia or event talking to a therapist ...

A clinical trial is underway to test a drug-free stimulation therapy to see if it can relieve symptoms of postpartum depression.